Register for our global webinar next week on November 3 2022, the first episode of a series of webinars with Professor Tom Brown at University of Oxford, recent advancement in oligonucleotide therapeutics will be covered.
Register: https://t.co/5zXWCwIjuW
#oligonucleotide
ATDbio (part or Biotage) is sponsoring the Aptamer and Oligo2022 conferences. If you are interested in highly modified and/or big scale oligonucleotide synthesis contact us! 🧬🧪⚗️
.@Biotage has acquired the UK’s @ATDBio for £45 million. The company said ATDBio’s expertise in highly complex #DNA and #RNA production provides market access and know-how in the rapidly growing #oligonucleotide sector. ATDBio had 2020 net sales of £3.5m. https://t.co/6irrJfzTpf
We are proud to be sponsoring @Oxford_IF this year. The festival has a fantastic programme of events which will play an important role in inspiring the next generation of scientists.
This Month's Featured Member of the Month is @Prof_Tom_Brown, Ph.D. He loves tackling problems in oligonucleotide chemistry and helping biologists to develop clinical applications by offering new chemical solutions.
https://t.co/3hkq7zK6kH
#oligotherapeutics#oligonucleotide
ATDBio is proud to have been admitted on to the Innovate UK EDGE Scaleup Programme, which supports a select group of companies on a journey to exponential growth #scaleupprogramme#innovateuk https://t.co/HNGPT1ZLxZ
Thrilled to share our #preprint and my first lead author publication on our method for performing direct @nanopore droplet based single-cell transcriptome sequencing! A🧵 https://t.co/sH7G6XFSSm
Fantastic work by the two genii Adam and Martin with our friends and colleagues at ATDBio and BMS -
Highly accurate barcode and UMI error correction using dual nucleotide dimer blocks allows direct single-cell nanopore transcriptome sequencing https://t.co/SrCTyTP9Zt
On Wednesday, we had a first network meeting with the newly recruited NATURE-ETN ESRs.
A great occasion to virtually meet each other and have an outlook on the next year and beyond! #H2020 @MSCActions
Feeling over the moon!🤩 My first author paper is out in @NatureComms !!
Great collaborative work done during my PhD at @RicciLab , together with @ATDBio , in which we demonstrate the use of IgG antibodies to control DNA-templated chemical reactions
https://t.co/ebGUlVjINm
Really happy to share the latest work from our group published in @NatureComms. Here we demonstrate how to repurpose IgG antibodies to boost different chemical reactions. Kudos to first-author @Lorenabp9 for this! https://t.co/klFUyfoqW0. Short thread below: 1/n
Our collaborator @RicciLab's paper on Using antibodies to control DNA-templated chemical reactions is published in @NatureComms today https://t.co/mTF12fX498